Patient Square Capital Finalizes Business Deal

Image Credit: AInvest

Announcement

Patient Square Capital, an affiliate of an investment firm, acquired healthcare firm Premier with a finalized deal value of approximately $2.6 billion. Patient Square Capital will pay $28.25 in cash for each share for premier and 9.7% premium to the stock’s last close. The premier coordinates with health systems, other providers, and hospitals to reduce costs and enhance patient care by supporting the purchase of supplies and equipment. Alongside Patient Square is an ambitious healthcare investment firm. The deal was announced on Monday morning, under regulatory approvals and shareholders’ sign-offs, and is further predicted to close by the first quarter of 2026.

The deal is not subject to financing conditions and eliminates the cash dividend mentioned by Premier’s board for future quarters and last month itself. The premier’s leadership mentioned that the deal would help new capital to structure and form the best healthcare service and product offering. Apart from group purchasing, the premier’s vast offerings for payers, suppliers, and providers focus on additional performance analytics and data, consulting, and supply chain. It also persuades numerous providers to partner on huge payments, workforce innovation, quality, organizational priorities, and population health management.

The premier includes above two-thirds of all US healthcare providers in its customer base. The company represents $84 billion in purchasing and around 3,000 active negotiated contracts, along with over 1,400 manufacturers and suppliers. The deal will strengthen and support the healthcare finance ecosystem and further pave the way for new technology and innovation to enter the wide range of the healthcare market. The acquisitions will allow expansion and advancement.

Views and statements from the company leaders

Premier’s board chair, Richard Statuto, said, “We are proud and excited to be able to reach this agreement and also glad that Patient Square values and is committed to improving Premier’s integral role and responsibility in the US health care system. The board collectively approved this transaction after carefully analyzing a wide range of smart options in recent years and consulting with our legal and financial advisors. We hope this transaction will be in the best interest of Premier and its stockholders. Further, on closing, it will provide certain and immediate value to our stockholders, also enabling the company with the availability of additional capital that can leverage the services and support provided to other customers and members during this crucial time in health care.”